Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 130,133 | 181,271 | -44,815 | -21,797 | -120,548 |
| Depreciation Amortization | 5,119 | 32,444 | 2,519 | 1,247 | 5,019 |
| Income taxes - deferred | -6,014 | -6,014 | N/A | N/A | N/A |
| Accounts receivable | -50,608 | -50,917 | 344 | 1,534 | -1,099 |
| Accounts payable and accrued liabilities | 20,097 | -645 | -13,842 | -8,171 | -19,913 |
| Other Working Capital | -58,287 | -80,262 | -17,401 | -8,481 | -44,774 |
| Other Operating Activity | 73,367 | 62,301 | 20,675 | 10,048 | 32,708 |
| Operating Cash Flow | $113,807 | $138,178 | $-52,520 | $-25,620 | $-148,607 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -155,785 | -46,387 | -15,106 | 79,600 | 169,671 |
| PPE Investments | -70 | -70 | -70 | -70 | -95 |
| Purchase Of Investment | N/A | N/A | N/A | -87,256 | N/A |
| Investing Cash Flow | $-155,855 | $-46,457 | $-15,176 | $-7,726 | $169,576 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 12,529 |
| Debt Repayment | -1,285 | -963 | -643 | -321 | -14,533 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 732 |
| Common Stock Repurchased | -941 | -941 | -941 | -941 | -972 |
| Financing Cash Flow | $-2,226 | $-1,904 | $-1,584 | $-1,262 | $-2,244 |
| Beginning Cash Position | 80,386 | 80,386 | 80,386 | 80,386 | 61,661 |
| End Cash Position | 36,112 | 170,203 | 11,106 | 45,778 | 80,386 |
| Net Cash Flow | $-44,274 | $89,817 | $-69,280 | $-34,608 | $18,725 |
| Free Cash Flow | |||||
| Operating Cash Flow | 113,807 | 138,178 | -52,520 | -25,620 | -148,607 |
| Capital Expenditure | -70 | -70 | -70 | -70 | -95 |
| Free Cash Flow | 113,737 | 138,108 | -52,590 | -25,690 | -148,702 |